The Enterprise Value as of June 2026 (TTM) for Cidara Therapeutics, Inc. (CDTX) is 5.32B

According to Cidara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.32B. This represents a change of 1.18% compared to the average of 415.34M of the last 4 quarters.

Cidara Therapeutics, Inc. (CDTX) Historical Enterprise Value (quarterly & annually)

How has CDTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Cidara Therapeutics, Inc. over the last ten years is 41.96M. The current 5.32B Enterprise Value has changed 1.27% with respect to the historical average. Over the past ten years (40 quarters), CDTX's Enterprise Value was at its highest in in the September 2025 quarter at 1.20B. The Enterprise Value was at its lowest in in the June 2024 quarter at -105121185.12.

Cidara Therapeutics, Inc. (CDTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cidara Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cidara Therapeutics, Inc. (CDTX) Average Enterprise Value

How has CDTX Enterprise Value performed in the past?

The current Enterprise Value of Cidara Therapeutics, Inc. (CDTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cidara Therapeutics, Inc. (CDTX) Enterprise Value vs. Peers

How is CDTX’s Enterprise Value compared to its peers?

Cidara Therapeutics, Inc.’s Enterprise Value is greater than Mineralys Therapeutics, Inc. (1.45B), greater than Adaptive Biotechnologies Corporation (2.95B), greater than Scholar Rock Holding Corporation (5.07B), greater than IDEAYA Biosciences, Inc. (2.42B), greater than Zai Lab Limited (1.37B), greater than Beam Therapeutics Inc. (2.95B), greater than Catalyst Pharmaceuticals, Inc. (3.09B), less than Legend Biotech Corporation (6.38B), greater than Disc Medicine, Inc. (2.54B), greater than Agios Pharmaceuticals, Inc. (1.67B),

Build a custom stock screener for Cidara Therapeutics, Inc. (CDTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cidara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cidara Therapeutics, Inc. (CDTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cidara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.